Cameco Corporation (CCJ) announced a profit for nine months that Drops, from last year
The company's bottom line totaled C$199 million, or C$0.46 per share. This compares with C$391 million, or C$0.90 per share, last year.
Excluding items, Cameco Corporation reported adjusted earnings of C$279 million or C$0.64 per share for the period.
The company's revenue for the period fell 0.1% to C$2.278 billion from C$2.281 billion last year.
Cameco Corporation earnings at a glance (GAAP) :
-Earnings: C$199 Mln. vs. C$391 Mln. last year.-EPS: C$0.46 vs. C$0.90 last year.-Revenue: C$2.278 Bln vs. C$2.281 Bln last year.
For comments and feedback contact: [email protected]
October 27, 2026 07:42 ET November brings a new lineup of FDA regulatory milestones that could influence biotech stocks. This video highlights five biotech companies to watch ahead of their upcoming FDA decisions, spanning potential treatments for sickle cell disease, psychiatric disorders, cardiovascular conditions, and cancer.